Fair Value Measurement (Tables)
|
3 Months Ended |
Mar. 31, 2025 |
|---|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
|
| Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis |
The following tables present the Company’s fair value hierarchy for its financial instruments that are measured at fair value on a recurring basis.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
10,016 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
10,016 |
|
|
|
$ |
10,016 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
10,016 |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Long-term liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Credit Agreement Warrants |
|
$ |
— |
|
|
$ |
7,790 |
|
|
$ |
— |
|
|
$ |
7,790 |
|
Securities Purchase Agreement Warrants |
|
|
|
|
|
1,264 |
|
|
|
|
|
|
1,264 |
|
Contingent earnout liability |
|
|
— |
|
|
|
— |
|
|
|
417 |
|
|
|
417 |
|
|
|
$ |
— |
|
|
$ |
9,054 |
|
|
$ |
417 |
|
|
$ |
9,471 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2024 |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
3,157 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
3,157 |
|
|
|
$ |
3,157 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
3,157 |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Long-term liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Credit Agreement Warrants |
|
$ |
— |
|
|
$ |
13,641 |
|
|
$ |
— |
|
|
$ |
13,641 |
|
Contingent earnout liability |
|
|
— |
|
|
|
— |
|
|
|
1,455 |
|
|
|
1,455 |
|
|
|
$ |
— |
|
|
$ |
13,641 |
|
|
$ |
1,455 |
|
|
$ |
15,096 |
|
|
| Summary of Change in Fair Value of Level 3 Financial Instruments |
The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis:
|
|
|
|
|
|
|
|
Contingent
Earnout
Liability |
|
|
Fair value as of December 31, 2024 |
|
$ |
1,455 |
|
|
Change in fair value of contingent earnout liability |
|
|
(1,038 |
) |
|
Fair value as of March 31, 2025 |
|
$ |
417 |
|
|
|
| Schedule of Cash and Cash Equivalents |
The following tables summarize the Company’s cash and cash equivalents by significant category:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
|
|
Amortized Cost |
|
|
Unrealized Gains |
|
|
Unrealized Losses |
|
|
Fair Value |
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash |
|
$ |
25,915 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
25,915 |
|
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
|
10,016 |
|
|
|
— |
|
|
|
— |
|
|
|
10,016 |
|
|
|
$ |
35,931 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
35,931 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2024 |
|
|
|
Amortized Cost |
|
|
Unrealized Gains |
|
|
Unrealized Losses |
|
|
Fair Value |
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash |
|
$ |
16,049 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
16,049 |
|
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
|
3,157 |
|
|
|
— |
|
|
|
— |
|
|
|
3,157 |
|
|
|
$ |
19,206 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
19,206 |
|
|
| Contingent Earnout Liability |
|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
|
| Schedule of Quantitative Information Contingent Earnout Liability |
The table below quantifies the significant inputs used for the contingent earnout liability:
|
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
|
December 31, |
|
|
|
2025 |
|
|
|
2024 |
|
Fair value of the Company’s Class A common stock |
|
$ |
8.09 |
|
|
|
$ |
14.07 |
|
Risk-free interest rate |
|
|
3.98 |
% |
|
|
|
4.22 |
% |
Expected volatility factor |
|
|
108.0 |
% |
|
|
|
96.0 |
% |
Earnout expiration date |
|
August 16, 2026 |
|
|
|
August 16, 2026 |
|
|
| Credit Agreement Warrants |
|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
|
| Schedule of Quantitative Information Contingent Earnout Liability |
The table below quantifies the significant inputs used for the Credit Agreement Warrants:
|
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
|
December 31, |
|
|
|
2025 |
|
|
|
2024 |
|
Fair value of the Company’s Class A common stock |
$ |
|
8.09 |
|
|
$ |
|
14.07 |
|
Exercise price |
$ |
5.44 - 16.08 |
|
|
$ |
5.44 - 16.08 |
|
Risk-free interest rate |
|
|
4.09 |
% |
|
|
|
4.48 |
% |
Expected volatility factor |
|
|
108.0 |
% |
|
|
|
96.0 |
% |
Expected dividend yield |
|
|
— |
% |
|
|
|
— |
% |
Remaining contractual term (in years) |
|
7.2 - 8.5 |
|
|
|
7.4 - 8.7 |
|
|